Wikidata

(Q28203323)

English

A Phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer

scientific article (publication date: May 2003)

In more languages

Statements

title
A Phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer (English)
0 references
author
Lorelei J Hanson
series ordinal
8
object named as
Lorelei H Hanson
0 references
Gerd Ritter
series ordinal
15
object named as
Gerd Ritter
0 references
Lloyd J. Old
series ordinal
22
object named as
Lloyd J Old
0 references
James N Ingle
series ordinal
12
object named as
James N Ingle
0 references
Andrew M Scott
series ordinal
1
object named as
Andrew M Scott
0 references
Sydney Welt
series ordinal
3
object named as
Sydney Welt
0 references
Fook-thean Lee
series ordinal
5
object named as
Fook-Thean Lee
0 references
Wendie Hopkins
series ordinal
6
object named as
Wendie Hopkins
0 references
Steven M. Larson
series ordinal
11
object named as
Steven M Larson
0 references
author name string
Greg Wiseman
series ordinal
2
0 references
Chaitan R Divgi
series ordinal
7
0 references
Paul Mitchell
series ordinal
9
0 references
Denise N Gansen
series ordinal
10
0 references
Eric W Hoffman
series ordinal
13
0 references
Paul Tanswell
series ordinal
14
0 references
Leonard S Cohen
series ordinal
16
0 references
Peter Bette
series ordinal
17
0 references
Lisa Arvay
series ordinal
18
0 references
Andree Amelsberg
series ordinal
19
0 references
Dan Vlock
series ordinal
20
0 references
Wolfgang J Rettig
series ordinal
21
0 references
Alex Adjei
series ordinal
4
0 references
publication date
May 2003
0 references
volume
9
0 references
issue
5
0 references
page(s)
1639-47
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q28203323&oldid=2185981840"